Oral mucositis: etiology, and clinical and pharmaceutical management.

International journal of pharmaceutical compounding

Volumn 16, Issue 1, 2012, Pages 22-33

  Zur, Eyal ^a  

^a Super Pharm   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

DRUG FORMULATION; ECONOMICS; HUMAN; PRACTICE GUIDELINE; RADIOTHERAPY; REVIEW; RISK FACTOR; STOMATITIS; WHOLE BODY RADIATION;

ANTINEOPLASTIC AGENTS; DRUG COMPOUNDING; HUMANS; PRACTICE GUIDELINES AS TOPIC; RADIOTHERAPY; RISK FACTORS; STOMATITIS; WHOLE-BODY IRRADIATION;

EID: 84868236519     PISSN: 10924221     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)